India Biosimilar Market Trends, Growth, and Demand Forecast 2025-2033
India Digital Payment Market Overview
Base Year: 2024
Historical Years: 2019-2024
Forecast Years: 2025-2033
Market Growth Rate: 23.2% (2025-2033)
India digital transactions market is booming fast. More people are using smartphones. So, the government is stepping in to help this growth. The fintech industry and cashless economy are transforming payments with new ideas. According to the latest report by IMARC Group, the India digital payment market size reached USD 5.48 billion in 2024. Looking forward, IMARC Group expects the market to reach USD 42.61 billion by 2033, exhibiting a growth rate (CAGR) of 23.2% during 2025-2033.
India Digital Payment Trends and Drivers:
The India biosimilar market is growing fast. This growth comes from three key factors: rising demand for affordable biologic therapies, a strong biosimilar pipeline, and supportive government policies. Biosimilars provide a more affordable option for patients with chronic conditions, such as diabetes, cancer, and autoimmune disorders. These drugs help ease the financial burden caused by expensive originator biologics. India has a strong pharmaceutical infrastructure and excels in making generic drugs. This has made it a global leader in developing biosimilars. Biocon, Dr. Reddy’s, and Intas Pharmaceuticals lead the way in biosimilars. They are rolling out drugs like trastuzumab, rituximab, and adalimumab. The market is growing thanks to more exports to regulated markets like the U.S. and Europe. Indian biosimilars are becoming popular there because they are affordable and high quality. Partnerships between Indian firms and global companies boost innovation and expand market reach. Challenges such as tough regulations and strict quality standards still slow growth. Also, doctors' hesitance to use biosimilars holds back progress. We need to tackle these issues.
Cancer cases are rising, and healthcare providers are accepting biosimilars more. This is driving growth in the segment. New biomanufacturing technologies improve production efficiency and lower costs. This includes single-use bioreactors and continuous processing. The Indian government is encouraging local biosimilar production. It uses the Production-Linked Incentive (PLI) scheme for pharmaceuticals. Patient access programs and awareness campaigns are key. They help reduce skepticism and boost adoption. New players are entering the market and investing in R&D. which is increasing competition. As a result, prices are becoming more affordable, and product offerings are improving. India is boosting its regulatory framework and aligning with global standards. This growth is setting the stage for the biosimilar market. It presents big opportunities for both local and international players.
Download a sample copy of the Report: https://www.imarcgroup.com/india-digital-payment-market/requestsample
India Digital Payment Industry Segmentation:
The report has segmented the market into the following categories:
Component Insights:
- Solutions
- Application Program Interface
- Payment Gateway
- Payment Processing
- Payment Security and Fraud Management
- Transaction Risk Management
- Others
- Services
- Professional Services
- Managed Services
Payment Mode Insights:
- Bank Cards
- Digital Currencies
- Digital Wallets
- Net Banking
- Others
Deployment Type Insights:
- Cloud-based
- On-premises
End-Use Industry Insights:
- BFSI
- Healthcare
- IT and Telecom
- Media and Entertainment
- Retail and E-commerce
- Transportation
- Others
Regional Insights:
- North India
- West and Central India
- South India
- East and Northeast India
Competitive Landscape:
The competitive landscape of the industry has also been examined, along with the profiles of the key players.
Key highlights of the Report:
- Market Performance (2019-2024)
- Market Outlook (2025-2033)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current, and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian